Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$306.88 - $380.0 $864,174 - $1.07 Million
-2,816 Reduced 4.93%
54,335 $20.6 Million
Q3 2023

Oct 25, 2023

SELL
$315.92 - $397.36 $1.82 Million - $2.29 Million
-5,754 Reduced 9.15%
57,151 $18.2 Million
Q2 2023

Aug 03, 2023

SELL
$346.15 - $392.09 $22.5 Million - $25.5 Million
-65,075 Reduced 50.85%
62,905 $24.1 Million
Q1 2023

Apr 24, 2023

SELL
$323.56 - $373.36 $132,659 - $153,077
-410 Reduced 0.32%
127,980 $47.8 Million
Q4 2022

Feb 14, 2023

SELL
$248.67 - $334.17 $1.25 Million - $1.68 Million
-5,019 Reduced 3.76%
128,390 $42.4 Million
Q3 2022

Oct 07, 2022

BUY
$263.81 - $337.27 $146,414 - $187,184
555 Added 0.42%
133,409 $35.2 Million
Q2 2022

Aug 10, 2022

BUY
$301.4 - $428.42 $756,212 - $1.07 Million
2,509 Added 1.92%
132,854 $41.6 Million
Q1 2022

May 13, 2022

SELL
$379.46 - $424.54 $13.5 Million - $15.1 Million
-35,461 Reduced 21.39%
130,345 $54.4 Million
Q4 2021

Feb 14, 2022

BUY
$373.53 - $434.12 $22.5 Million - $26.2 Million
60,277 Added 57.12%
165,806 $69.5 Million
Q3 2021

Nov 08, 2021

BUY
$396.76 - $455.92 $7.75 Million - $8.9 Million
19,528 Added 22.71%
105,529 $43.6 Million
Q2 2021

Aug 11, 2021

BUY
$372.36 - $412.07 $31.2 Million - $34.5 Million
83,694 Added 3627.83%
86,001 $34.1 Million
Q1 2021

May 14, 2021

BUY
$357.26 - $392.57 $196,850 - $216,306
551 Added 31.38%
2,307 $886,000
Q4 2020

Feb 10, 2021

BUY
$319.05 - $363.32 $70,191 - $79,930
220 Added 14.32%
1,756 $638,000
Q3 2020

Nov 13, 2020

SELL
$280.08 - $347.78 $21.9 Million - $27.2 Million
-78,171 Reduced 98.07%
1,536 $518,000
Q2 2020

Aug 13, 2020

SELL
$270.93 - $320.3 $21.8 Million - $25.7 Million
-80,392 Reduced 50.21%
79,707 $22.6 Million
Q1 2020

May 14, 2020

BUY
$243.44 - $359.98 $9.45 Million - $14 Million
38,814 Added 32.0%
160,099 $44.1 Million
Q4 2019

Feb 13, 2020

BUY
$281.18 - $322.05 $3.5 Million - $4.01 Million
12,451 Added 11.44%
121,285 $39 Million
Q3 2019

Nov 14, 2019

BUY
$294.25 - $341.49 $31.8 Million - $36.9 Million
108,185 Added 16669.49%
108,834 $32.3 Million
Q2 2019

Aug 14, 2019

SELL
$279.29 - $336.89 $26,532 - $32,004
-95 Reduced 12.77%
649 $219,000
Q1 2019

May 15, 2019

SELL
$246.18 - $297.25 $138,106 - $166,757
-561 Reduced 42.99%
744 $220,000
Q4 2018

Feb 06, 2019

BUY
$232.7 - $281.66 $15,823 - $19,152
68 Added 5.5%
1,305 $332,000
Q3 2018

Nov 15, 2018

BUY
$236.3 - $277.15 $52,458 - $61,527
222 Added 21.87%
1,237 $343,000
Q2 2018

Aug 13, 2018

BUY
$217.98 - $237.23 $221,249 - $240,788
1,015 New
1,015 $239,000
Q4 2017

Feb 13, 2018

SELL
$217.88 - $244.43 $22.9 Million - $25.7 Million
-105,131 Closed
0 $0
Q3 2017

Nov 13, 2017

SELL
$231.6 - $253.39 $6.96 Million - $7.62 Million
-30,061 Reduced 22.24%
105,131 $24.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
135,192
135,192 $32.4 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.7B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.